Close Menu
  • News
  • Home
  • In Profile
  • Finance
  • Legal
  • Technology
  • Events
  • Features
  • Wellbeing & Mental Health
  • Marketing
  • HR & Recruitment
  • About
  • Advertise
  • Events Calendar
  • Business Wall
  • Subscribe
  • Contact
  • 0843 289 4634
X (Twitter) LinkedIn YouTube
Trending
  • Three Feet From Gold
  • Comment on V-Level Qualifications
  • Increasing employer pension contributions could push 1 in 6 firms to insolvency
  • Forget AI job fears – new report says majority of firms want to invest in MORE accountants 
  • What makes work meaningful for employees?
  • The smarter path to global growth – why strategy must come before scale
  • Making Tax Digital: Compliance burden or productivity boost?
  • Double Celebration For Entrepreneur As She Scoops National And Local Awards
X (Twitter) LinkedIn YouTube
SME Today
  • About
  • Advertise
  • Events Calendar
  • Business Wall
  • Subscribe
  • Contact
  • 0843 289 4634
  • News
  • Home
  • In Profile
  • Finance
  • Legal
  • Technology
  • Events
  • Features
  • Wellbeing
  • Marketing
  • HR & Recruitment
SME Today
  • About
  • Advertise
  • Events Calendar
  • Business Wall
  • Subscribe
  • Contact
  • 0843 289 4634
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
You are at:Home»News»Daemon reduces Tachmed’s scientists’ clinical investigation time by 50% with AI
Daemon reduces Tachmed’s scientists' clinical investigation time by 50% with AI, accelerating breakthroughs in healthcare diagnostics

Daemon reduces Tachmed’s scientists’ clinical investigation time by 50% with AI

0
Posted By Greg Robinson on March 13, 2025 News, Technology

Digital transformation consultancy Daemon announces new collaboration with UK-based healthcare company Tachmed  to enhance the speed and efficiency of bringing innovative healthcare products to the market faster. By leveraging AI to identify clinical uses and antibodies for testing, the collaboration enables Tachmed to streamline its workflows, saving as much as 50% of time that would’ve previously been spent conducting this in-depth research without support.

To accelerate clinical and use-case identification and reduce delays in developing Tachmed’s extensive assay library, Tachmed collaborated with Daemon to identify the most impactful opportunities for AI integration. Through stakeholder engagement, two-way education, upskilling initiatives and hands-on workshops, Daemon worked closely with scientists to understand key challenges in clinical use-case identification. This foundational work helped shape AI adoption, minimising delays in developing Tachmed’s extensive assay (test) library and ensuring scientists could focus on high-value research.

Innovation with AI, the Daemon way

Tachmed’s success relies on rapid discovery and evaluation of potential clinical use cases and diagnostic reagents, such as antibodies, for assay development. Previously, scientists manually sifted through scientific literature and vendor data, a process that was time-consuming, costly and prone to bottlenecks.

Daemon identified a three-step approach to using AI to eliminate these hurdles:

  1. Using AI to extract the right information: Using Anthropic’s Claude’s Sonnet 3.5, available through Amazon Bedrock, the AI model extracts insights from PubMed and vendor websites. The AI also extracts antibody data.
  2. Organising information for ease of use: Once the AI has extracted the key data, again powered by Anthropic’s Claude on AWS Bedrock, it organises it with two steps. First, it identifies key details, biomarkers, test types, and clinical significance. Then it synthesises the extracted data to deliver targeted, actionable, and organised insights, enabling scientists to make informed decisions without sifting through vast amounts of research or spreadsheets. This approach helps researchers efficiently identify biomarkers and clinical opportunities, accelerating assay development, saving time, and supporting faster, data-driven decision-making.
  3. A scalable system for the future: Built on AWS’s managed services, the system is designed to scale with Tachmed’s growing needs, ensuring smooth performance and efficient data processing, even as the volume of information increases. AWS’ scalable infrastructure supports long-term growth while maintaining seamless operation.

To ensure rapid and effective adoption of AI solutions, Daemon also educated scientists, developers, and non-technical stakeholders on AI’s capabilities, helping to build a long-term, scalable vision. Additionally, Daemon designed and implemented a tailored user interface with an iterative approach, incorporating user feedback and testing.

Damien Duff, Principal Consultant, Machine Learning at Daemon comments, “We are committed to helping organisations harness AI to drive meaningful change. This project exemplifies how AI can improve efficiency and unlock new opportunities for innovation. By automating critical processes and enabling faster decision-making, we’re empowering scientists to focus on the breakthroughs that matter.

“Our work with Tachmed demonstrates that AI and innovation create significant opportunities to accelerate the development of healthcare products.”

Delivering measurable impact

The collaboration between Daemon and Tachmed hasrated significant real-world impact, empowering innovation as Tachmed’s team now has access to AI-driven tools to quickly discover clinical use cases and antibody candidates, driving their mission to create transformative healthcare solutions. It has also accelerated development, with the tool saving scientists up to a week on every two-week literature review and up to a week per clinical project, thereby speeding up research and reducing time-to-market for new healthcare products. Additionally, what started as a proof of concept is now in active use and ready to scale,architecture set to automate data scraping and handle larger datasets; future developments will extend AI capabilities to support data analysis and testing processes. already demonst with AI-driven

Paul Christie, CEO, Tachmed comments, “Daemon’s expertise and collaboration has been instrumental in helping us build tools that align with our mission to transform healthcare data and diagnostics. The AI-powered system the team developed is already saving us time, delivering valuable insights, and enabling us to innovate faster.

“It is the first step of using AI to revolutionise assay development and moving downstream to frontline remote, predictive, and automated user applications. This partnership is a game-changer.”

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Double Celebration For Entrepreneur As She Scoops National And Local Awards

AI Is Not A Strategy. It’s How The Next Generation Of Businesses Will Operate

Global Connectivity in 2026

Comments are closed.

Follow SME Today on Linkedin and share all the topics you find interesting
ISO/IEC 27001 roadmap: A practical guide for UK SMEs
ISO/IEC 27001 roadmap: A practical guide for UK SMEs
Are you a Company Director?
Are you a Company Director - Verify your identity
Mastermind9
Events Calendar
    • Marketing
    October 30, 2025

    Three Feet From Gold

    October 14, 2025

    Do You Need To Look Through ‘The Business Lens’?

    • Finance
    October 30, 2025

    Increasing employer pension contributions could push 1 in 6 firms to insolvency

    October 29, 2025

    Forget AI job fears – new report says majority of firms want to invest in MORE accountants 

    • People
    October 13, 2025

    Dr. Karim Bahou appointed Head of Innovation at Sister, Manchester’s £1.7bn innovation district

    September 30, 2025

    Allergen Free For The Win: Ceo Of Inclusive Food Brand Announced As Best Business Woman

    • Health & Safety
    September 18, 2025

    Lessons From Grenfell Are Still Being Learned

    September 2, 2025

    1 in 3 employees anxious about lack of first aiders at work

    • Events
    October 10, 2025

    Nominations Now Open for UK’s Top 100 Businesses – EB100 2026

    October 8, 2025

    The Solopreneur Awards 2025: The Audacity Era

    • Community
    September 18, 2025

    ClearCourse appoints new Chair of the Board, Simon Black

    September 18, 2025

    Raising Money Where It’s Needed: Westspring Pledges To Raise £50,000 For Charity

    • Food & Drink
    October 15, 2025

    Stockley’s Moves To New Purpose-Built Facility To Support Ambitious Expansionist Vision

    October 9, 2025

    Leading Allergy Campaigner Supports Call For New Food Allergens To Be Added To Uk’s ‘Top 14’ List

    • Books
    September 3, 2025

    New book on conquering fear of public speaking

    August 7, 2025

    Learning to Leave a Legacy in Business

    The Newsletter

    Join our mailing list for the best SME stories, handpicked and delivered direct to your inbox every two weeks!

    Sign Up
    About

    SME Today is published by the same team who deliver The Great British Expos’. We have been organising various corporate events for the last 10 years, with a strong track record of producing well managed and attended business events across the UK.

    Join Our Mailing List

    Receive the latest news and updates from SMEToday.
    Read our Latest Newsletter:


    Sign Up
    X (Twitter) YouTube LinkedIn
    Categories
    • Books
    • Community & Charity
    • Education and Training
    • Environment
    • Events
    • Features
    • Finance
    • Food and Drink
    • Health & Safety
    • HR & Recruitment
    • In Profile
    • Legal
    • Marketing
    • News
    • People
    • Property & Development
    • Sponsored Content
    • Technology
    • Transport & Tourism
    • Wellbeing & Mental Health
    • ABOUT SME TODAY: THE GO TO RESOURCE FOR UK BUSINESSES
    • Editorial Submission Guidelines
    • Privacy
    • Contact
    Copyright © 2025 SME Today.
    • ABOUT SME TODAY: THE GO TO RESOURCE FOR UK BUSINESSES
    • Editorial Submission Guidelines
    • Privacy
    • Contact

    Type above and press Enter to search. Press Esc to cancel.